SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-21-082602
Filing Date
2021-06-17
Accepted
2021-06-17 16:08:16
Documents
2
Period of Report
2021-06-15

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2119990d5_4.html 4  
1 OWNERSHIP DOCUMENT tm2119990d5_4.xml 4 5781
2 EXHIBIT 24 tm2119990d5_ex24.htm EX-24 8789
  Complete submission text file 0001104659-21-082602.txt   16086
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GERON CORPORATION 230 CONSTITUTION DRIVE MENLO PARK CA 94025
Business Address
Spiegel Robert J. (Reporting) CIK: 0001492256 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50626 | Film No.: 211024780